Clinical Trial Update: Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study [NA]

View source ↗

Summary

The HiPPI study is evaluating hypofractionated proton therapy for benign intracranial brain tumors and is currently recruiting. It targets meningiomas, schwanno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma
• Pituitary Adenoma
• Schwannoma

Snippet

Sponsor: Emory University | Conditions: Grade I Meningioma, Grade II Meningioma | NA | Status: RECRUITING